Slider-web-1 – NH

“Amicapsil changed my life.”

“From 4 weeks of absolute hell – to being pain-free, getting a full night’s sleep and back to normal at work.”

“From 4 weeks of absolute hell, in pain 24 hours a day, struggling at work – to being pain-free, getting a full night’s sleep and back to normal at work.”

“From 4 weeks of absolute hell, in pain 24 hours a day, struggling at work – to being pain-free, getting a full night’s sleep and back to normal at work.”

NH ( patient)

NH ( patient)

NH ( patient)

Slider-web-AMR

Effective treatment of wounds and pressure ulcers in SCI-persons and in controlling soft tissue infection caused by osteomyelitis

Effective treatment of wounds and pressure ulcers in SCI-persons and in controlling soft tissue infection caused by osteomyelitis

Effective treatment of wounds and pressure ulcers in SCI-persons and in controlling soft tissue infection caused by osteomyelitis.

Slider-web-AMR

See video, where Lady-Marie from UK Spinal Injuries Association describes how Amicapsil has treated her pressure injuries

Slider-web-1

“Where I have used Acapsil the scarring is flat, whereas the older scars are hypertrophic.” Patient ST

“Where I have used Acapsil the scarring is flat against the surrounding skin, whereas the older scars are bulging / hypertrophic.” Patient ST

“Where I have used Aprobaxil the scarring is flat against the surrounding skin, whereas the older scars are bulging / hypertrophic.” Patient ST

Is MPPT safe?

The components of MPPT are approved food supplements without any known cytotoxicity.
MPPT has been shown to cause no wound irritation, sensitisation or bleeding.
MPPT is not absorbed by the body and can be rinsed off by irrigation with water or wiped off with a moist swab. It can remain on the clean wound surface after discontinuation and will fall off as healing progresses.

Related Posts

June 20’th, 2024 – Patient survey of MPPT published in Frontiers in Rehabilitation Sciences

The British Spinal Injuries Association SIA has published a user-survey in Frontiers in Rehabilitation Sciences: Patient-reported outcome survey of user-experiences

January 5’th, 2024 – MPPT clinical study published in Frontiers in Medicine

The clinical trial “Stable closure of acute and chronic wounds and pressure ulcers and control of draining fistulas from osteomyelitis